Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × merphos × 1 year × Clear all

Sponsor

Conditions

Burkitt Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 6 Leukemia, Biphenotypic, Acute 6 Myelodysplastic Syndromes 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myeloid, Accelerated Phase 3 Blast Crisis 3 Lymphoma, Mantle-Cell 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Urinary Bladder Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Primary Myelofibrosis 1 Osteosarcoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Mouth Neoplasms 1 Medulloblastoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Down Syndrome 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Rituximab 41 Cyclophosphamide 31 Lenalidomide 24 fludarabine 19 zanubrutinib 12 venetoclax 11 obinutuzumab 11 fludarabine phosphate 9 Bendamustine Hydrochloride 9 orelabrutinib 8 ibrutinib 8 Vincristine 8 Magnetic Resonance Spectroscopy 8 pirtobrutinib 7 Whole-Body Irradiation 7 Prednisone 7 Specimen Handling 6 Doxorubicin 6 CT-P10 6 Mycophenolic Acid 5 Etoposide 5 Biopsy 5 pembrolizumab 4 Nivolumab 4 Melphalan 4 tafasitamab 3 Sirolimus 3 Cyclosporine 3 parsaclisib 2 copanlisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡